• Skip to main content
  • Skip to primary sidebar
  • Home
  • News
  • Marketplace
  • Events
  • Education
  • Interviews
    • Career spotlight
  • Opinion
    • Professional Dilemmas
    • Patient perspective
  • PIPcast
  • Jobs

Pharmacy in Practice

EDX/20/1154
Date of prep: December 2020

Prescribing information and
adverse events reporting

For healthcare professionals only

GPhC issue improvement notice after finding serious failures

29th October 2020 by PIP editor Leave a Comment

 

The General Pharmaceutical Council (GPhC) has issued an improvement notice to Clear Chemist requiring it to take measures to rectify failures identified at an intelligence-led inspection.

 

The GPhC had previously taken the unusual decision to make a statement about Clear Chemist.

 

At an inspection on 5th October, GPhC inspectors identified that the pharmacy was not meeting some of the standards for registered pharmacies that provide the framework to ensure safe and effective care for patients and the public.

 

The inspectors found ‘serious system-wide failures in the governance and management of risk at the pharmacy and a lack of safeguarding’. The GPhC has said that this presents a risk to patient safety.

 

The inspectors considered the volume and type of medicines supplied, the age range and potential vulnerability of the patients, and the additional risks of working with prescribers based in the EEA and working outside UK regulatory oversight.

 

The improvement notice requires the pharmacy to put a number of measures in place to rectify the failures and meet the standards, including developing and putting in place a comprehensive risk assessment for the services they provide and updating their safeguarding policy and procedures. These measures will help to protect patient safety.

 

The improvements required are as follows:

 

  • The pharmacy must develop and put in place a comprehensive risk assessment that covers each individual service the pharmacy provides at a distance. The risk assessment must be documented and should identify each of the medicines you are supplying, the conditions they are being used to treat and the associated risks. The risk assessment must take account of the age range of the patients being treated and the way in which the online prescribers are managing their treatment. The pharmacy will need to be able to demonstrate the action taken to mitigate the risks identified and show that there is a clear plan in place, with timelines, setting out how systems and processes within the pharmacy will change to manage the risks.
  • The pharmacy must develop and put in place a comprehensive contingency plan to provide continuity of care for their patients in the event of any breaks in service.
  • The pharmacy must put in place and implement clear procedures for the pro-active and regular review of the quality of services provided with regard to the supply of medicines prescribed by online providers. The pharmacy will need to provide evidence of these procedures, showing that they are embedded within the pharmacy working processes, with specific reviews and audits scheduled which link to the risks identified in your risk assessments.
  • The pharmacy must review and update your safeguarding policy and procedures taking account of the risks identified in the risk assessment and make sure there is a clear plan in place to implement any changes required to the system. The pharmacy must be able to demonstrate that the pharmacy team have been trained on the updated policy and procedures to ensure that safeguarding risks are effectively managed.

 

The deadline for compliance was set as 18th November 2020.

Next article  Good Scottish representation at the RPS #fellowsdinner

 

Duncan Rudkin, Chief Executive of the GPhC, said:

 

“We know that people receiving medicines from Clear Chemist have been concerned about how our actions may affect them.

 

“We want to reassure everyone that we have not asked the pharmacy to stop supplying medicines to patients undergoing treatment for gender dysphoria. We have directed the pharmacy to make improvements to make sure that people receive medicines that are safe and effective for them.

 

“Our inspectors will continue to work with the superintendent pharmacist to make the improvements needed and to support continuity of care for the pharmacy’s patients.”

 

 

Share this:

  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to share on Twitter (Opens in new window)
  • Click to share on WhatsApp (Opens in new window)
  • Click to share on Telegram (Opens in new window)
  • Click to email this to a friend (Opens in new window)

Related

Filed Under: News

About PIP editor

Pharmacy in Practice is a UK pharmacy publication with its roots in Scotland.

Reader Interactions

Begin the discussion right here Cancel reply

Primary Sidebar

Stay connected with us

  • E-mail
  • Facebook
  • Instagram
  • LinkedIn
  • Phone
  • Twitter

Your Pharmacy in Practice Prescription

Categories

Pharmacy in Practice member login

 
 
Forgot Password

Register for our upcoming live Q&A

https://www.youtube.com/watch?v=vVNhKJWCGFA

© 2021 · About Pharmacy In Practice · Site mantained by Mike

This site is for healthcare professionals, please confirm you are a healthcare professional to continue.

YES

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
Pharmacy In Practice uses cookies, by continuing to use this site we will assume you are ok with that Find out more.